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SUMMARY 
Endocannabinoids (eCBs) exert major control over neuronal activity by activating cannabinoid 
receptors (CBRs). The functionality of the eCB system is primarily ascribed to the well-
documented retrograde activation of presynaptic CB1Rs. We find that action potential-driven eCB 
release leads to a long-lasting membrane potential hyperpolarization in hippocampal principal 
cells that is independent of CB1Rs. The hyperpolarization, which is specific to CA3 and CA2 
pyramidal cells (PCs), depends on the activation of neuronal CB2Rs as shown by a combined 
pharmacogenetic and immunohistochemical approach. Upon activation, they modulate the 
activity of the sodium-bicarbonate co- transporter, leading to a hyperpolarization of the neuron. 
CB2R activation occurred in a purely self-regulatory manner, robustly altered the input/output 
function of CA3 PCs and modulated gamma oscillations in vivo. To conclude, we describe a cell 
type-specific plasticity mechanism in the hippocampus that provides evidence for the neuronal 
expression of CB2Rs and emphasizes their importance in basic neuronal transmission. 
 
 
 
  
2 
INTRODUCTION  
The eCB system is one of the main neuromodulatory systems acting in the CNS and is highly 
conserved across species (Liu et al., 2009). It predominantly functions by modulating neural 
excitability through presynaptic inhibition of transmitter release and eCB-dependent forms of 
short- and long-term plasticity (Brenowitz and Regehr, 2005; Carta et al., 2014; Chevaleyre and 
Castillo, 2004; Hájos et al., 2002; Kim and Alger, 2010; Marsicano et al., 2003; Monory et al., 
2006; Stella et al., 1997). Endocannabinoid-mediated plasticity mechanisms are found at both 
excitatory and inhibitory synapses in most brain areas (Kano et al., 2009) and they primarily 
depend on a Ca2+-dependent postsynaptic release of eCBs and the retrograde activation of 
presynaptically located CB1Rs, which are abundantly expressed in most cell types (Katona and 
Freund, 2012; Katona et al., 1999). The retrograde mode of action has first been described for 
two prominent forms of eCB-mediated short-term synaptic depression: depolarization-induced 
suppression of inhibition (DSI) and excitation (DSE, for reviews see (Castillo et al., 2012; Wilson 
and Nicoll, 2002)). Yet, depending on the mode of activation, they mediate long-term forms of 
eCB-mediated plasticity of transmitter release as well (Chevaleyre and Castillo, 2003; Gerdeman 
et al., 2002; Robbe et al., 2002).  
In stark contrast to the vast amount of literature on CB1R-mediated phenomena, very little is 
known about the relevance of CB2Rs in neuronal signaling. Indeed, until recently the CB2R was 
referred to as the ‘peripheral’ CBR reflecting its predominant expression in organs of the immune 
system (Munro et al., 1993) where it participates in the regulation of immune responses and is 
responsible for the anti-inflammatory effects of cannabis (Buckley et al., 2000). A major problem 
of studying CB2Rs has been their low expression levels in the CNS and the lack of reliable 
antibodies, which has sparked controversy concerning their localization in the brain (Baek et al., 
2013; Marchalant et al., 2014). Yet, the generation of CBR knockout (KO) mice (Buckley et al., 
2000; Zimmer et al., 1999) and the production of a diverse array of synthetic cannabinoid agents 
have advanced and facilitated research on CB2Rs. Especially behavioral studies have advocated 
the presence of CB2Rs in the CNS (Onaivi, 2006; Van Sickle et al., 2005) with properties that 
extend their neuro-immunological function. Anatomical and electrophysiological studies support 
this notion and suggest a role of CB2Rs in neural transmission and excitability (den Boon et al., 
2012; Gong et al., 2006; Morgan et al., 2009). In the hippocampus, the presence of CB2Rs has 
been suggested (Brusco et al., 2008; Kim and Li, 2015; Li and Kim, 2015) but their physiological 
role is uncertain. Furthermore, it is not clear whether they are expressed neuronally or mainly in 
cells of the immune system, such as microglia (Schmöle et al., 2015).  
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In this paper, we provide in vitro and in vivo evidence that functional CB2R are expressed 
neuronally in the hippocampus and that they mediate a self-regulatory eCB-mediated plasticity in 
a distinct subset of hippocampal principal cells via modulation of the sodium/bicarbonate co-
transporter (NBC). 
 
RESULTS 
Backpropagating Action Potentials Induce a Cell Type-Specific Hyperpolarization in 
Hippocampal Principal Cells 
In response to trains of action potentials (APs) we observed a long-lasting membrane potential 
(Vm) hyperpolarization in CA3 pyramidal cells (PCs), which outlasts the classic 
afterhyperpolarization (AHP). The hyperpolarization persisted for the duration of the recording (up 
to 20min after the induction), was as large as ~10mV (Figure 1A), and was present in all cells 
tested when recorded in perforated patch (pp) configuration, in which the intracellular milieu of 
the recorded cell remains undisturbed. When repeating the above experiment in whole-cell (wc) 
configuration, we observed a fraction of unresponsive cells, which might explain why this form of 
plasticity has not been observed before and thus a cut-off was introduced to classify cells as 
‘reactive’ and ‘unreactive’ (Figures S1A-B, and see methods). We compared different recording 
parameters and found a significant correlation between the access resistance (Ra) and the degree 
of hyperpolarization (Figures S1C-F). We furthermore performed a subset of wc recordings with 
a potassium gluconate-based internal solution (instead of methanesulfonate), or with 1mg/ml 
biocytin, in both of which we observed a complete abolition of the hyperpolarization (data not 
shown). Although the reasons for this are unresolved, many studies have previously reported that 
internal solutions and anions alter and interfere with membrane properties (Eckert et al., 2001; 
Kaczorowski et al., 2007). 
To elucidate whether this hyperpolarization is a mechanism common to all hippocampal 
principal cell types or displays cell-type specificity, we examined CA1 PCs and dentate gyrus 
granule cells (DG GCs, both recorded in pp configuration), as well as CA2 PCs. In contrast to 
CA3 PCs that hyperpolarized to similar extents independent of their location within CA3, neither 
CA1 PCs nor DG GCs hyperpolarized in response to AP trains (Figures 1B-C). This induction 
failure could be the result of a different induction threshold. To test for this, we used a theta-
frequency burst protocol, consisting of four times as many APs as the standard protocol (see 
methods), that is known to trigger eCB-mediated long-term depression (LTD) in these cells 
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(Younts et al., 2013). However, this also failed to induce a long-lasting hyperpolarization in CA1 
PCs (Figures S2A-C). Contrary to this, morphologically identified CA2 PCs do express this form 
of cellular plasticity (Figures S2D-F).   
The Long-Lasting Hyperpolarization Is Dependent on the Release of Endogenous 2-AG and 
Neuronal Cannabinoid Type 2 Receptors  
What could be the underlying mechanism of this self-inhibitory long-term plasticity? eCBs are 
known to modulate many forms of long-term plasticity in the CNS (Chevaleyre et al., 2006) and 
high frequency stimulation (HFS) has been shown to lead to release of 2-arachidonoylglycerol (2-
AG) in hippocampal slices (Stella et al., 1997). To assess whether the activity-dependent release 
of 2-AG – the most ubiquitous eCB in the CNS that is synthesized and released upon a sufficient 
rise in intracellular calcium (Sugiura et al., 2002) – mediates the plasticity, we recorded from mice 
lacking the 2-AG-synthesizing  enzyme DAGLα (Jenniches et al., 2015). To confirm the lack of 2-
AG synthesis in the DAGLα KOs, we recorded DSI in DAGLα-/- CA3 PCs since 2-AG is the main 
eCB involved in both DSI and DSE (Hashimotodani et al., 2008). In contrast to WT controls, DSI 
was completely abolished in DAGLα-/- CA3 PCs as measured by the change in amplitude and 
frequency of spontaneous inhibitory postsynaptic currents (sIPCSs, Figures 2A-B). Next, we 
tested whether lack of 2-AG would have an effect on the AP-mediated hyperpolarization and found 
that it was also absent in these animals (Figures 2C-D), thereby establishing that this effect is 
dependent on AP-driven 2-AG release.  
 
The main CBRs that eCBs act on are CB1 and CB2. Previously, it has been reported that CB1Rs 
activate G protein-coupled inwardly-rectifying potassium channels (GIRK) on subsets of cortical 
neurons in response to AP trains (Bacci et al., 2004; Marinelli et al., 2009). This phenomenon, 
termed slow self-inhibition (SSI), also leads to a long-lasting Vm hyperpolarization. To test whether 
the same mechanism may underlie the hyperpolarization, we recorded CA3 PCs from CB1R-/- 
mice, but found that the effect was fully intact in these animals (Figure 3A). We then recorded 
CA3 PCs from CB2R-/- mice – the other main CBR. Surprisingly, the effect was absent in these 
animals, suggesting that CB2Rs mediate the long-lasting hyperpolarization (Figure 3B).  
Assuming that CB2Rs mediate the AP-induced hyperpolarization, preincubation of slices 
with CBR antagonists should abolish the effect in WT and as well as CB1R KO animals. Firstly, 
we confirmed that the percentage of reactive cells recorded in wc configuration was comparable 
between CB1R-/- and WT CA3 PCs, and that the hyperpolarization was absent in CB2R KOs 
(Figures S3A-B). We then preincubated slices with the mixed cannabinoid inverse agonist AM-
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251 that, as predicted, blocked the AP-induced hyperpolarization in both WT and CB1R-mutant 
CA3 PCs (Figures S3C-D). It is of note that this result indicates that AM-251 efficiently targets 
CB2Rs at concentrations that are commonly considered to be CB1R-specific (2-5µM). In addition, 
we preincubated slices from CB1R-/- mice with the CB2R-specific inverse agonist SR144528 (SR) 
that successfully blocked the hyperpolarization in all cells tested (Figures S3C-D). These results 
support the presence of functional CB2Rs that can be blocked pharmacologically.  
 
It is known that CB2Rs are expressed in macrophage lineage cells including microglia that have 
been shown to modulate neuronal transmission (Salter and Beggs, 2014). Furthermore, as of yet, 
direct evidence for the neuronal expression of CB2Rs is still negligible, due to the lack of specific 
antibodies and neuron-specific genetic manipulations. Thus, to verify this unexpected finding and 
in order to test for the neuronal expression of CB2Rs we generated a neuron-specific CB2R KO 
mouse in which the CB2R-encoding gene Cnr2 is deleted under a synapsin promoter via the 
Cre/loxP system (Syn-CB2R KO, see methods and Figure S4). We find that in these mice the 
hyperpolarization was equally absent as in the constitutive KO (Figure 3C). Importantly, the 
hyperpolarization in the CB2R+/+ littermate controls was not different from C57BL/6 WT (Mann-
Whitney test: P=0.67, Figure 3D). As a general control for the properties of CA3 PCs recorded 
from the mutant mice used, we compared their basic intrinsic physiological properties, which were 
not different from C57BL/6 or littermate WT mice (Figure S3E). Thus any changes observed are 
unlikely to stem from differences in their basal properties. In summary, these results strongly 
suggest that the hyperpolarization depends on the activation of neuronal CB2Rs and is 
independent of CB1R activation (Figures 3E-F).  
To support this finding, we performed in situ hybridization assays (ISH) for CB2R mRNA 
in hippocampi of Syn-CB2R KO (Figures 4A-C and S4) and CB2R KO (Figure S6) mice. Figure 4 
shows the RNAscope ISH results, illustrating co-localization of Cnr2 (green) and Rbfox3 (a 
neuronal marker gene that encodes NeuN, red) in the majority of hippocampal neurons in the 
CA3 region in WT, but not in Syn-CB2R KO mice (Figures 4A-C). We detected similar amounts 
of CB2R mRNA in area CA2, but much lower levels in areas CA1 and DG (Figure S5).  
We noted that Cnr2 was still detectable in hippocampal tissue of Syn-CB2R KO mice 
(Figure 4C, lower panels), which may reflect Cnr2 expression in glial cells. To test this hypothesis, 
we used fluorescence-activated cell sorting (FACS) to separate hippocampal neuronal cells and 
glial cells (Fig. 4D), and then used quantitative PCR (qPCR) to measure Cnr2 expression levels 
in each cell population. We find that Cnr2 is mainly expressed in NeuN+ cells (neurons) in WT, 
while it was substantially reduced (~70% reduction) in Syn-CB2R KO and completely abolished 
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in CB2R KO mice (Fig. 4E). As expected, we detected CB2R mRNA also in non-neuronal cells in 
WT and Syn-CB2R KO, but not in CB2R KO mice (Figure 4E). Unexpectedly, low levels of Cnr2 
gene are still detectable in NeuN+ cells in Syn-CB2R KO mice (Fig. 4E), which may be related to 
the impurity of the sorted neurons; e.g. a small fraction of glial cells may 'contaminate’ the NeuN+ 
population. To test this hypothesis, we examined Rbfox3 and the glial marker genes Itgam, Cspg4 
and Aldh1L1, which encode CD11b (a microglial marker), NG-2 (an oligodendrocyte marker) and 
ALDH1L1 (an astrocyte marker) respectively, in each cell population. We detect a small 
percentage (~25%) of glial markers in the NeuN+ population (Figure 4G-a). Since glial cells also 
express Cnr2 (Figure 4E), this may well explain why low levels of Cnr2 expression (~30%) are 
detectable in NeuN+ cells of Syn-CB2R KO mice. As a control, we analyzed the same samples 
for CB1R mRNA expression, which was not different between NeuN+ (and NeuN-) cells of WT, 
Syn-CB2R KO and CB2R KO mice (Figure 4F). To further confirm this finding, we compared Cnr2 
expression between WT, CB1R and CB2R KO mice with classical ISH in combination with 
immunostainings. We find a similar degree of co-localization of Cnr2 with NeuN and vGluT2 (a 
marker for glutamatergic neurons) in WT and CB1R KO mice, while Cnr2 is undetectable in the 
CB2R KO (Fig. S5). 
 
The activity-induced hyperpolarization can be mimicked and occluded by CBR agonists 
As a further line of evidence supporting the presence of functional CB2Rs, we tested whether we 
can mimic the AP-driven hyperpolarization by directly activating CB2Rs pharmacologically. The 
mixed CBR agonists 2-AG and WIN,55212-2 (WIN), as well as the CB2R-specific agonist HU-308 
(HU), all strongly hyperpolarized CA3 PCs in WT mice (Figures 5A-C,E-F). To confirm that the 
drug-induced hyperpolarization is indeed due to CB2R activation and as a control for the 
specificity of HU for CB2Rs at the concentration used, we tested 2-AG and HU in slices of and 
(Syn-)CB2R-/- mice. Neither of the drugs led to a hyperpolarization in these animals, strongly 
arguing for a purely CB2R-dependent mechanism (Figures 5D-F). Additionally, late application of 
AM-251 could reverse the hyperpolarization induced by 2-AG, arguing for the same target 
receptor (Figure 5G). To substantiate the assumption of a shared CB2R-dependent mechanism 
between AP-dependent release of endogenous 2-AG and exogenously applied CBR agonists, we 
performed occlusion experiments. When the agonist HU was applied before AP trains, and also 
when these stimuli were applied in the reverse sequence, the maximal CB2R activation via one 
process occluded the other, as the respective second stimulus failed to elicit an additional 
hyperpolarization (Figures 5H-I). 
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The hyperpolarization is mediated by a G Protein- and sodium-dependent modulation of 
the NBC 
As CBRs are G Protein-coupled receptors (GPCRs), we confirmed that the hyperpolarization is 
mediated by a G Protein-dependent cascade by performing experiments with 0.5mM GDPßS, a 
non-hydrolysable GDP analog that blocks G protein-coupled activity. The inclusion of GDPßS into 
the pipette abolished the pharmacologically-induced hyperpolarization within the manipulated 
neuron (Figures 6A-B), supporting the idea of a cell-intrinsic, G Protein-dependent mechanism. 
CBRs, like many other neuronal GPCRs, couple to GIRK channels (Ho et al., 1999; Mackie 
et al., 1995) which at a first glance appear as a likely downstream target of CB2R activation to 
mediate the hyperpolarization via an extrusion of potassium from the cell. However, when 
analyzing the pharmacologically induced hyperpolarization, we observed no change in input 
resistance concurrent with the hyperpolarization (Figures 6C-E). As a control for a GPCR-
dependent activation of GIRK, we recorded from CA3 PCs and applied 1μM Adenosine that is 
known to act on adenosine receptors that in turn activate GIRK. As expected for a conductance-
based mechanism, we find a significant reduction of the Rin that is furthermore reversed by the 
GIRK antagonist SCH-23390 (Figure S7A). In contrast to this, the acute application of SCH-23390 
failed to repolarize the Vm of CA3 PCs after the successful induction of the hyperpolarization by 
both AP- dependent release of 2-AG and pharmacological CB2R activation (Figure S7B). We also 
analyzed the current-voltage relationship with step protocols before and after CB2R activation 
(Figure 6E). To conclude, in contrast to cortical SSI, which is mediated by GIRK channels, this 
set of experiments strongly argues against a conductance-based process and the involvement of 
GIRK channels in the hyperpolarization. 
Next, we thus investigated the involvement of ionic gradients and electrogenic pumps. In 
a first set of experiments we blocked the sodium/chloride co-transporter KCC2 (with 10µM 
VU0240551), the sodium/potassium/chloride co-transporter NKCC (with 10µM Bumetanide) and 
the sodium/hydrogen exchanger (with 10µM Cariporide), but could not antagonize the long-lasting 
hyperpolarization. Further, we removed either chloride or potassium from the media, however, the 
effect was still fully intact (data not shown). Finally, replacing sodium with N-Methyl-D-glucamin 
(NMDG) resulted in a complete abolishment of the agonist-induced hyperpolarization (Figure 6F). 
Furthermore, preincubation with a specific blocker of the NBC prevented the long-lasting 
hyperpolarization, both for agonist as well as AP-driven induction (Figures 6F-J), arguing for the 
specific involvement of the NBC. To rule out that mere interference with the Vm – via the change 
of intra- and extracellular sodium concentrations – occludes the hyperpolarization, we 
preincubated slices with a blocker for the sodium/potassium pump that is expressed in CA3 PCs 
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and has been shown to hyperpolarize neurons in an activity-dependent manner as well 
(Gustafsson and Wigström, 1983). Yet, in the presence of 10µM ouabain, the hyperpolarization 
was fully intact (in contrast to NBC block and NMDG replacement, summary graph: Figures 6I-J). 
To conclude, we found that the hyperpolarization is dependent on a) extracellular sodium and its 
gradient across the membrane and b) the activity of the NBC. 
 
Acute reversal of the hyperpolarization by CB2R inverse agonists 
What is the underlying cause of the long-lasting nature of the hyperpolarization? HFS can 
increase 2-AG levels for several minutes (Stella et al., 1997) and it has been shown that eCB-
mediated LTD of inhibitory inputs can be reversed by applying AM-251 5min, but not 10min, after 
the induction (Chevaleyre and Castillo, 2003). Additionally, it has previously been suggested that 
antagonists can acutely reverse other forms of long-term plasticity such as mGluR-dependent 
LTD (Palmer et al., 1998) which is likely to be due to a persistent receptor activation even in an 
agonist-unbound state (Lodge et al., 2013). To test for these possibilities, we firstly performed 
control recordings in WT CA3 PCs for >25min to confirm the feasibility of pharmacological 
manipulation during longer recordings (Figures S8A-B). In a separate set of experiments, we then 
acutely applied the CB2R-specific inverse agonist SR after eliciting the hyperpolarization in CA3 
PCs with the AP protocol. We found that late application of SR repolarized the Vm back to its 
baseline levels in all cells tested (Figures S8C-E). Because we applied the drug at different time 
points (~5-15min after the induction, Figure S8C) and could reverse the hyperpolarization even 
15min after induction, it is unlikely to still depend on elevated 2-AG levels. Thus, this data set 
suggests that constitutive receptor activation may be the mechanism underlying the persistency 
of this particular form of plasticity. We performed these experiments in CB1R-/- animals to eliminate 
possible off-target effects of the pharmacological agent.  
 
Comparison of CB2R- versus presynaptic eCB-mediated effects 
Do CB2Rs also modulate ‘classic’ eCB-mediated alterations of presynaptic function and does the 
hyperpolarization have similar characteristics? First, we tested whether the hyperpolarization 
depends on synaptic transmission and found that it was intact in block of both excitatory and 
inhibitory transmission (Figure 7A). Second, DSI has been shown to be a mechanism that acts in 
an auto- and paracrine manner (Kreitzer et al., 2002; Wilson and Nicoll, 2001 but see Younts et 
al., 2013). To test if the AP-driven release of 2-AG by one neuron is sufficient to elicit a 
hyperpolarization in neighboring neurons, we performed dual pp recordings of adjacent CA3 PCs 
(distance between pipette tips: 11±1.2µm) and found no evidence for a detectable ‘spread’ of the 
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effect between PCs (Figure 7C-D). Third, to test whether CB2R activation could mimic DSI, we 
recorded evoked IPSCs (eIPSCs) in CA3 PCs and induced DSI by depolarization of the recorded 
neuron. Conversely, subsequent application of 1µM HU did not alter the eIPSC amplitude of DSI+ 
neurons (Figure 7E). Additionally, the reduction of field excitatory postsynaptic potentials 
(fEPSPs, recorded in CA3) observed upon application of the mixed CBR agonist WIN, which is 
also ascribed a presynaptic mode of action (Takahashi and Castillo, 2006), could not be mimicked 
by HU (Figure 7F). To conclude, the hyperpolarization appears to be a solely self-regulatory cell-
intrinsic mechanism that acts complementary to presynaptic CBRs.  
 
Physiological stimulation and functional significance of CB2Rs  
We assessed the functional significance of CB2R activation on both a single cell and network 
level. In stark contrast to the so far employed artificial fixed-frequency induction protocol, both the 
frequency and amount of neuronal spiking in vivo are irregular, highly variable and temporally 
complex. CA3 PCs in particular are known to spike frequently when recorded in vivo, both as 
single spikes and in bursts (Sneider et al., 2006). We thus considered whether physiologically 
relevant activity patterns are able to induce the hyperpolarization and constructed a spike train 
based on in vivo place field firing patterns of CA3 PCs (see methods). Indeed, we found that this 
physiological spike train (PST) elicited a hyperpolarization with an average ΔVm that did not differ 
from the standard protocol (unpaired t-test: p=0.42, Figures 8A-C). 
Next, we investigated whether the long-lasting hyperpolarization affects the output of CA3 
PCs. We therefore compared the spike probability of synaptically evoked AP firing in CA3 PCs 
before and after the application of HU. In those cells that hyperpolarized (wc: 5/8 reactive cells) 
we find a simultaneous, robust reduction in spike probability by >80% (Figures 8D-F). To test 
whether this was causally linked to the hyperpolarization induced by the CB2R agonist, we 
“clamped” the cells to their initial baseline Vm with constant current injection at the end of each 
experiment. As expected, this was sufficient to restore the initial spike probability in all neurons 
(0.93±0.04, normalized to 1). Conversely, when we manually hyperpolarized the unreactive cells 
with current injections (baseline Vm: -64.7±0.8mV, hyperpolarized Vm: -72.5±0.5mV), we were 
able to mimic the reduction in spike probability induced by the CB2R agonist-mediated 
hyperpolarization (0.1±0.036, normalized to 1). In summary, these experiments indicate that the 
Vm hyperpolarization following activation of CB2Rs significantly shifts the rheobase of CA3 PCs 
and profoundly reduces their input/output function.   
Finally, to study the role of CB2R signaling in network dynamics we recorded local field 
potentials (LFP) in area CA3 of freely behaving mice that were systemically treated with the CB2R 
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agonist HU, or vehicle. LFP oscillations in the slow gamma band (30-85Hz), generated locally in 
area CA3 (Csicsvari et al., 2003), and theta (5-10Hz) oscillations determine hippocampal network 
synchronization and information processing during exploratory behavior. During baseline 
recordings and after vehicle administration, the amplitude of gamma oscillations changed as a 
function of the theta phase, more pronounced variations of gamma amplitude were found during 
theta cycles of higher amplitude (Figure 8G, upper panel), in agreement with earlier reports 
(Schomburg et al., 2014; Wulff et al., 2009). In contrast, following the agonist administration, slow 
gamma modulation was significantly less strongly determined by changes of theta oscillation 
amplitude in WT mice (Figure 8G, lower panel) but not in Syn-CB2R-/- mice (F1,10=0.3, p=0.59). 
The power of theta and gamma oscillations as well as the theta modulation of intermediate (65-
120Hz) gamma oscillations were not affected by the agonist treatment (power: F1,13=1.0, p=0.33 
and F1,13=1.5, p=0.24; modulation: Figure 8H). Additional LFP recordings in area CA3 of behaving 
Syn-CB2R-/- mice and their WT littermates revealed a reduced power of gamma oscillations in the 
mutant (Figure S9). Altogether, these results suggest that neuronal CB2Rs regulate gamma 
oscillations in area CA3 in vivo. 
 
Discussion  
CB2Rs have been reported to be modulated during a variety of complex neuropsychiatric 
disorders including depression, schizophrenia and autism spectrum disorders and, due to their 
non-psychotropic mode of action, are considered promising therapeutic targets (Onaivi, 2011). 
Yet, in contrast to the well-established function and localization of CB1Rs, little is known about 
their role in basic neurotransmission. By providing a first description of functional, neuronally 
expressed CB2Rs in area CA3 of the hippocampus, our findings now reveal a novel role for CB2Rs 
in the CNS and challenge the classic, CB1R-focused view on eCB function. 
In summary, we find that neuronal CB2Rs mediate a long-lasting, cell-intrinsic 
hyperpolarization in hippocampal principal neurons of areas CA3 and CA2. The CB2R-dependent 
hyperpolarization can be triggered via the release of endogenous 2 -AG or by direct 
pharmacological receptor activation. Because it is long-lasting in its nature and is additionally 
independent of excitatory and inhibitory synaptic transmission, it appears to be an intrinsic 
plasticity process that negatively modulates the excitability of CA3 PCs. 
 
Cell type-specific expression of the CB2R-mediated plasticity. The AP-dependent 
hyperpolarization can only be induced in CA3 and CA2 PCs, which resemble each other in their 
electrophysiological properties (Wittner and Miles, 2007) but not in the other two main principal 
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cell populations of the hippocampus, namely CA1 PCs and DG GCs. This may be either due to a 
lack of CB2R protein or due to an induction failure. The former is unlikely since we detect low 
levels of CB2R mRNA in these cell populations as well. We thus tested the latter hypothesis and 
found that we can readily induce a hyperpolarization of CA1 PCs by pharmacological activation 
of CB2Rs with both HU and WIN (data not shown). In combination with the finding that even strong 
stimuli, that are known to trigger eCB-mediated LTD at this synapse (Younts et al., 2013), failed 
to elicit a hyperpolarization, these results supports the notion that functional CB2Rs are present 
in CA1 (and DG) but are not activated by physiological activity. Possible explanations for this 
induction failure are manifold, including differences in the expression levels and distribution of the 
CB2R or other components of the ECS, and highlight the fact that the development of specific 
CB2R antibodies (Baek et al., 2013; Marchalant et al., 2014) is crucially important to determine 
their expression on a (sub-) cellular level.  
 
Neuronal expression of functional CB2Rs in area CA3. The expression of CB2Rs in the CNS 
has been subject to much debate (Onaivi, 2006), with many published studies being unable to 
detect any CB2R mRNA or ligand binding in brain preparations or only in microglia (Buckley et 
al., 2000; Galiègue et al., 1995; Schmöle et al., 2015). However, behavioral and 
electrophysiological studies have suggested the functional presence of CB2Rs (Onaivi, 2006; Van 
Sickle et al., 2005; Xi et al., 2011; Zhang et al., 2014). Therefore, the question remains: are CB2Rs 
expressed in neurons? To address this question, we generated a novel, neuron-specific CB2R 
KO to use in combination with electrophysiological and molecular biology techniques: firstly, the 
finding that the CB2R-mediated hyperpolarization is absent in the neuron-specific CB2R KO 
argues for the presence of functional neuronal CB2Rs at a protein level. Secondly, by means of 
ISH (with a fluorescence double-labelling strategy) and FACS/qPCR assays, we are able to 
demonstrate the expression of CB2R mRNA in hippocampal glutamatergic neurons and, more 
specifically, CA3 PCs. Taken together, this data provides strong and direct evidence for the 
neuronal expression of functional CB2Rs in the CNS. 
 
What underlies the long-lasting hyperpolarization mechanistically? Surprisingly, the 
hyperpolarization was not accompanied by a change in membrane resistance, which rules out the 
involvement of a conductance-based mechanism (unlike cortical SSI (Bacci et al., 2004)) and 
suggests the involvement of an ion pump or co-transporter. CBRs have before been shown to 
modulate the activity of ion co-transporters, such as the sodium/hydrogen exchanger (Bouaboula 
et al., 1999). Following this lead, we performed experiments with NMDG-based sodium 
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replacement that hinted towards a sodium-dependent process. Finally, block of the NBC by a 
specific antagonist abolished both the AP-driven and pharmacologically induced 
hyperpolarization, suggesting it to be the downstream target of CB2R activation.  
The NBC is a member of the SLC4 solute carrier family and plays an important role in 
intracellular pH regulation by accumulating intracellular bicarbonate driven by the inwardly 
directed sodium gradient (for a review see (Ruffin et al., 2014)). Hippocampal PCs express NBCs 
(Majumdar et al., 2008) and functional studies indicate a role in pH regulation during neuronal 
activity (Chesler and Kaila, 1992). Our study provides the first evidence for a functional coupling 
between cannabinoid signaling and the NBC. Future studies will discover the molecular 
mechanisms involved in this interaction.  
 
A possible cause for the long-lasting hyperpolarization upon CB2R activation could be identified 
based on the observation that the acute application of a CB2R inverse agonist reversed the AP-
triggered hyperpolarization. Given that endogenous 2-AG is broken down rapidly (Sugiura et al., 
2002) and other studies estimated the prolonged presence of 2-AG after HFS to be ~5min 
(Chevaleyre and Castillo, 2003), it is unlikely that 2-AG remains available to constitutively activate 
the receptor up to 15min after induction. Thus, our data suggests that the transient stimulation of 
CB2Rs by activity-evoked release of 2-AG may alter their properties, rendering them persistently 
active in the absence of agonist, similar to observations on mGluRs (Lodge et al., 2013; Young 
et al., 2013). 
 
Complementary action of CB1- and CB2 receptors. As mentioned in the introduction, 
membrane-derived lipids including eCBs predominantly function through presynaptic inhibition of 
transmitter release. Only few studies have demonstrated changes in neuronal excitability that 
depend on cell-intrinsic eCB modulation (Bacci et al., 2004; den Boon et al., 2012). Thus the 
question arises, how might CB2R activation contribute to the fine-tuned, highly complex eCB 
neuromodulatory system that controls a single neuron’s physiology and excitability from 
presynaptic transmitter release to spike output?  
 Our data suggests that on a cellular level CB1- and CB2Rs may provide a non-overlapping 
functionality with CB1Rs being expressed mostly presynaptically and CB2Rs on postsynaptic 
compartments of hippocampal CA3/2 PCs. A complementary modulation of the auto-associative 
CA3 network by 1) CB1Rs that presynaptically modulate chemical transmission and alter synaptic 
weights of incoming inputs and 2) CB2Rs that alter the cell’s intrinsic properties in response to AP 
firing provides a powerful mechanism to fine-tune the network’s excitability. This seems especially 
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important in area CA3 and CA2 that are recurrently connected and thus particularly susceptible 
to hyperexcitability and imbalanced network states (Le Duigou et al., 2014; Sloviter, 1991). In line 
with this, the hypothesis of CB2Rs providing a functional ‘safety brake’ is plausible. Furthermore, 
given the long-lasting nature of the hyperpolarization, one might speculate that – especially during 
ongoing activity in vivo – CB2Rs will provide a rather ‘tonic’ inhibition. 
 
Physiological relevance of CB2R activation in the hippocampus. The in vivo and in vitro 
analysis of CB2R function shows that they impact the output of a single CA3 PC as well as altering 
locally generated network oscillations in the behaving animal. We show that physiological spike 
trains activate CB2Rs and that their activation reduces the spike probability of CA3 PCs. Our 
finding, that a change in the Vm strongly affects the input/output transformation of CA3 PCs, 
supports the idea that intrinsic membrane properties are highly relevant for single cell excitability 
and information processing (Kowalski et al., 2015; Lee et al., 2012). The hippocampus exhibits 
several functionally distinct types of gamma oscillations including locally generated, slow 
oscillations and intermediate/fast oscillations that originate in the entorhinal cortex and entrain the 
hippocampus (Colgin et al., 2009; Csicsvari et al., 2003; Schomburg et al., 2014). It is thought 
that the cross-frequency coupling of hippocampal theta and gamma oscillations as observed 
during exploratory behaviors may serve as coding scheme for working memory, and to provide 
the basis for simultaneously encoding of information at different time scales. In the CA3 area 
gamma oscillations arise from interactions between PCs and interneurons, rendering gamma-
synchronization sensitive to changes of excitability of these cell types (Buzsáki and Wang, 2012). 
We find that acute application of a CB2R agonist selectively affects the theta-dependent 
modulation of gamma oscillations in WT but not Syn-CB2R-/- mice and that Syn-CB2R-/- mice 
exhibit reduced power of gamma oscillations. In contrast, the effects of eCBs on network 
oscillations in vivo exerted via CB1Rs are widespread and affect synchronization across 
frequency bands (Robbe et al., 2006), suggesting a more specific involvement of CB2R in spatial 
coding modes supported by gamma oscillations (Bieri et al., 2014). To summarize, the reduced 
spike probability of CA3 PCs in vitro and the selective disruption of slow gamma oscillations by 
CB2Rs activation strongly suggest that neuronal CB2Rs are important modulators of local network 
rhythms. Recent studies have suggested that a lack of CB2Rs impairs hippocampal memory 
function (García-Gutiérrez et al., 2013; Li and Kim, 2016), similar to the effect of CB1R deficit in 
adult mice (Bilkei-Gorzo et al., 2005). Further electrophysiological and behavioral analysis of the 
Syn-CB2R KO will hopefully help us gain a better understanding of their role in hippocampal 
information processing on both a single cell and network level. 
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Conclusion 
In comparison to the vast literature on CB1R function in the CNS, the current state of knowledge 
concerning CB2Rs is negligible. It is thus crucial to highlight their importance in basic neuronal 
transmission. Our results provide a first in depth description of neuronal CB2R expression and 
their functional relevance in the hippocampus.  
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Experimental Procedures 
Ethical statement and animal handling. Animal husbandry and experimental procedures were 
performed in accordance with the guidelines of local authorities (Berlin, Germany), the German 
Animal Welfare Act and the European Council Directive 86/609/EEC. KO mice were maintained 
on a C57BL/6 genetic background and generated in the laboratory of A. Zimmer (Buckley et al., 
2000; Jenniches et al., 2015; Zimmer et al., 1999). Neuron-specific, conditional CB2R KO mice 
were generated by crossing mice expressing Cre recombinase under the Synapsin I promoter 
with floxed CB2R animals. 
In vitro electrophysiology. Electrophysiological recordings from hippocampal slices were made as 
described previously (Maier et al., 2011, 2012). The AP trains (inter-stimulus interval: 10ms, inter-
train interval: 20s) were induced with 2ms long, somatic current injections. Pharmacological 
agents were bath applied.  Sample sizes are given as the number of experiments (n) and of 
animals (N). Normally distributed data sets were compared with a two-tailed Student‘s t-test and 
values are expressed as mean±SEM. Nonparametric tests were used as indicated and data 
presented as median (with 25th and 75th percentile). Results were considered significant at p<0.05. 
Given Vm values are not corrected for liquid junction potential. In wc recordings, cells were 
classified as ‘reactive’ or ‘nonreactive’ based on a 2.1mV cut-off. 
In vivo electrophysiology. Mice were implanted with arrays of single tungsten wires in area CA3 
and the LFP was recorded while the animals explored freely in an open arena. After 1h of baseline 
recordings, animals were injected with either vehicle (10mg/kg DMSO) or with HU (10mg/kg, 
dissolved in DMSO) and were recorded in the arena for one more hour. Phase-amplitude coupling 
of theta and gamma oscillations was computed as described previously (Wulff et al., 2009). The 
statistical significance of comparisons was determined by a two-way ANOVA.  
Molecular Biology. Standard molecular biology techniques as well as classical ISH, RNAscope 
ISH and FACS assays were performed as described previously (Buckley et al., 2000; Li et al., 
2015; Liu et al., 2014; Zhang et al., 2014). For the RNAscope ISH in the Syn-CB2R KO, the probes 
Mm-Cnr2-O2 and Mm-Rbfox3-C2 were designed and provided by Advanced Cell Diagnostics Inc. 
For FACS, cells were sorted with a PE-labelled (fluorescent) anti-NeuN antibody (1:500; 
FCMAB317PE, Millipore) and validated the purity of the detected cell populations with qRT-PCR 
analysis of Rbfox3 and Itgam, Cspg4 and Aldh1l1. 
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Figure legends 
 
Figure 1. Action potential firing induces a cell type-specific Vm hyperpolarization in 
hippocampal principal cells. (A-C) Current injection-triggered AP trains (rectangle) induce a 
long-lasting Vm hyperpolarization in CA3 PCs (A) but not in CA1 PCs (B) and DG GCs (C). Left: 
exemplary pp recordings of each principal cell population. APs have been truncated and test 
pulses cut for display purposes in this and all later figures. Insets: firing patterns (scale bar: 40mV, 
0.2s). Right: summary time course of the ΔVm average for CA3 PCs: n(N)=17(13), CA1 PCs: 
n(N)=14(4) and DG GCs: n(N)=8(4). The x-axis is discontinued for the duration of the AP train. 
(D) The ΔVm of each recorded cell (circles) and the median, 25th and 75th percentile of the average 
ΔVm calculated from the first minute after the last AP train are shown for CA3 PCs (-4.1, -5.4 and 
-3.6mV), CA1 PCs (0.30, -0.15 to 0.68mV) and DG GCs (1.04, -0.35 to 1.8mV). Kruskal-Wallis 
with Dunn’s post-test: p<0.05 for CA3 PCs vs. CA1 PCs and DG GCs. (E) Percentage (%) reactive 
cells.  
Figure 2. The eCB 2-AG mediates the hyperpolarization. (A) As a control, sIPSCs were 
recorded from WT and DAGLα-/- CA3 PCs to test for the presence of DSI. In contrast to a DSI+ 
WT CA3 PC (upper trace), depolarization of a DAGLα-/- CA3 PC (0mV for 3x1s) failed to induce 
DSI (lower trace). (B) The normalized change in amplitude (left) and frequency (right) of sIPSCs 
in DAGLα-/- CA3 PCs (n(N)=3(1): 1.4±0.17 and 1.2±0.05) differed significantly from WT controls 
(n(N)=5(1)), 0.55±0.1 and 0.78±0.1, Mann-Whitney test: P=0.036). The absolute sIPSC amplitude 
and frequency after DSI induction in the DAGLα KO do not differ from baseline (Wilcoxon test: 
P=0.25). (C) Example Vm response of a DAGLα-/- CA3 PC to the AP stimulus (rectangle). (D) Left: 
the ΔVm of each recorded cell (circles) and the median, 25th and 75th percentile of the average 
ΔVm are shown for n(N)=6(3) experiments in pp (-0.2, -0.7 and 1.5mV; Wilcoxon test: P=0.84 in 
comparison to baseline). Right: % reactive cells. For statistical comparison, the Vm values from 
WT CA3 PCs (Figure 1) are re-plotted in grey (Mann Whitney test: p<0.0001). 
Figure 3. The long-lasting hyperpolarization is absent in CB2R-deficient mice. (A-C) AP 
trains (rectangle) induce a long-lasting hyperpolarization in CB1R-/- CA3 PCs (A) but not in CA3 
PCs of CB2R-/- (B) and Syn-CB2R-/- mice (C). Left: exemplary pp recordings of KO CA3 PCs. 
Right: summary time course of the average ΔVm of CA3 PCs recorded from CB1R-/-: n(N)=8(6), 
CB2R-/-: n(N)=15(7) and Syn-CB2R-/-: n(N)=8(5). The x-axis is discontinued for the duration of the 
AP train. (D) Same as (A-C) for WT littermate controls of CB2R-/- and Syn-CB2R-/- mice: 
n(N)=4(3)/4(2). (E) The ΔVm of each recorded cell (circles) and the median, 25th and 75th 
percentile of the average ΔVm (min9-10) are shown for CA3 PCs recorded in CB1R-/- (-4.3, -5.8 
and -2.6mV), (Syn-)CB2R+/+ littermates (-4.7, -5.8 to -3.5mV), CB2R-/- (0.39, -0.57 to 1.4mV) and 
Syn-CB2R-/- (0.53, 0.086 to 1.1mV). Kruskal-Wallis with Dunn’s post test: p<0.0001 for [WT and 
CB1R-/-] vs. [CB2R-/- and Syn-CB2R-/-]. The average ΔVm of WT vs. CB1R-/- and CB2R-/- vs. Syn-
CB2R-/- did not differ significantly. (F) % reactive cells.  
Figure 4. Neuronal CB2R mRNA expression in the hippocampus by RNAscope ISH and 
FACS-qPCR assays. (A) Hippocampal image (DAPI staining), illustrating the target region (CA3) 
in C. (B) The CB2R mRNA structure in CB2R-floxed mice and the target gene region of a CB2R 
RNAscope probe (CB2-O2, 506-934bp) used to detect CB2R mRNA. The CB2-O2 probe targets 
the floxed region of mouse CB2R mRNA (NM_009924.4) in CB2R-floxed mice. CDS, (CB2R)-
coding DNA sequence (478-1521bp). (C) CB2R mRNA staining illustrating significant CB2R (Cnr2, 
green) and NeuN (Rbfox, red) mRNA co-localization in WT hippocampal CA3 neurons (upper 
panels), while such co-localization is substantially diminished in Syn-CB2R-/- (lower panels). (D) 
A representative image of FACS-sorted NeuN+ neurons and NeuN- non-neuronal cells in the 
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hippocampus. (E) qPCR assays show that CB2R mRNA is detected mainly in NeuN+ 
hippocampal cells of WT mice, while the CB2R mRNA in NeuN+ hippocampal cells in Syn-CB2R-
/- mice was substantially reduced (~70% reduction), and abolished in the CB2R-/- mice. (F) qPCR 
assays for CB1R mRNA (as controls) in the same samples demonstrate similar levels of CB1R 
mRNA expression in NeuN+ neurons and NeuN- cells in WT, Syn-CB2R-/- and const. CB2R-/- mice. 
(G) qPCR assay results of neuronal and glial markers in two cell populations to examine the purity 
of sorted cells, illustrating that Rbfox3 was detected mainly in FACS-sorted NeuN+ neurons (a), 
but not in NeuN- cells (b). In contrast, the glial marker genes Itgam, Cspg4 and Aldh1l1 were 
mainly detected in NeuN- non-neuronal cells (b), but not in NeuN+ hippocampal neurons (a). Data 
shown in (a) was normalized to Rbfox3 expression in the NeuN+ population, which was defined 
as 1. Data shown in (b) was normalized to each respective marker gene level in NeuN+ (Rbfox3) 
and NeuN- cells (all three glial markers). 
Figure 5. CB2R agonists mimic and occlude the AP-driven hyperpolarization. (A-D) 
Exemplary Vm time courses of wc CA3 PC recordings are shown for the application of 10µM 2-
AG (A), 1µM WIN (B) and 1µM HU (C) that hyperpolarise CA3 PCs. The hyperpolarising effect of 
HU is gone in the CB2R-/- (D). (E-F) The ΔVm of each recorded cell (circles) and the median, 
25thand 75th percentile of the average ΔVm (E) as well as the % of reactive cells (F) are shown for 
the application of 2-AG in WT (wc, n(N)=15(5): -5.3, -9.0 to -3.9mV; 53.3%) and in CB2R-/- (pp, 
n(N)=5(2): 1.6, 0.5 to 2.2mV; 0%), WIN in WT (wc, n(N)=23(15): -4.2, -5.6 to -2.7mV; 60.9%), HU 
in WT (wc, n(N)=20(10): -7.6, -9.7 to -4.9mV; 60%), HU in CB2R-/- (wc, n(N)=12(3): 0.9, 0.3 to 
1.5mV; 8.3%), HU in Syn-CB2R-/- (wc, n(N)=14(5): 1.4, 0.3 to 3mV, 0%) and HU in Syn-CB2R+/+ 
(wc, n(N)=6(4): -7.5, -9 to -5.7mV; 50%). Note that the filled circles indicate reactive cells. Colour 
code: 2-AG/green, WIN/yellow and HU/blue. Kruskal-Wallis with Dunn’s post-test: p<0.05 for 2-
AG and HU in CB2R-/- vs. WT. (G) AM-251 reverses the hyperpolarization induced by 2-AG in 
n(N)=3(3) CA3 PCs (-5.3±0.9mV and -0.9±1mV respectively). (H) The HU-induced 
hyperpolarization (blue line) occludes further hyperpolarization of CA3 PCs in response to APs 
(rectangle) and vice versa. Exemplary ΔVm time courses of CA3 PCs that hyperpolarise in 
response to HU (left) and AP trains (right). (I) Single occlusion experiments (grey circles) and 
mean±SEM (black) are shown for each condition. Average ΔVm for HU followed by APs (left, 
n(N)=6(4): -6.6±1.3 and -7.8±1.9mV, paired t-test: P=0.24) and APs followed by HU (right, 
n(N)=6(6): -4.2±1.2 and -3.4±0.9mV, P=0.19). 
Figure 6. The hyperpolarization is mediated by a G Protein- and Na+-dependent modulation 
of the NBC. (A) Exemplary ΔVm time courses of wc CA3 PC recordings with internal application 
of 0.5mM GDPßS. The subsequent application of 1μM HU fails to hyperpolarise the CA3 PC. (B) 
The ΔVm of each recorded cell (circles) and the median, 25th and 75th percentile of the average 
ΔVm (left) as well as the % of reactive cells (right) are shown for GDPßS+HU (n(N)=15(5): 0.6, -
0.04 and 3.6mV; 13.3%) and are significantly different from control WT cells (ΔVm: p<0.0001, 
compare to Figure 5E). Note that the remaining reactive cells (indicted by filled circles) are most 
likely caused by an insufficient diffusion of GDPßS given the short incubation of 5min to prevent 
washout. (C) Exemplary Vm traces of reactive CA3 PCs recorded in wc configuration that 
hyperpolarized in response to 10µM 2-AG (left), 1µM WIN (middle) and 1µM HU (right). The Rin 
was calculated from the steady-state response to a -80pA test pulse. In each panel, the left trace 
represents the control condition (1min before agonist application) and the right trace is taken from 
5-10min after the drug was bath applied. The respective Vm values are indicated below each 
trace. (D) Summary bar graph of all reactive cells showing the normalized ΔRin (mean±SEM) after 
drug application for 2-AG (n=8: 1.1±0.1), WIN (n=14: 1.01±0.05) and HU (n=12: 1.2±0.1) that do 
not differ significantly from baseline levels (paired t-test for 2-AG, WIN and HU: P=0.30, 0.99 and 
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0.12). (E) IV plot of n(N)=4(2) reactive CA3 PCs that were recorded at different holding potentials 
in voltage clamp (-110 to 40mV, 10mV steps) before and after the application of HU. The 
hyperpolarization was not accompanied by a change in the IV relationship (normalized to -60mV, 
paired t-test: P=0.66). (F-H) Replacement of Na+ with NMDG in the ACSF as well as block of the 
NBC by preincubation of the antagonist S0859 abolished the hyperpolarization. Examples of ΔVm 
values for the application of HU in NMDG (D), HU in S0859 (E), and AP stimulation in S0859 in 
CA3 PCs (F). (I) The ΔVm of each recorded cell (circles) and the median, 25thand 75th percentile 
of the average ΔVm (left) as well as the % of reactive cells (right) are shown for the application of 
HU in NMDG (wc, n(N)=11(5): 1.9, -1.1 to 2.8mV; 0%), HU in S0859 (wc, n(N)=16(6): 0.01, -1.1 
to 1.7mV, 6.25%), APs in S0859 (wc, n(N)=23(9): 1.1, 0.1 to 3mV, 4.3%) and, as a control, HU in 
10µM ouabain (wc, n(N)=17(6), -5.8, -7.9 to -4.2mV, 52.9%). 
Figure 7. Comparison of CB2R- vs. presynaptic CBR-mediated effects. (A,B) The continuous 
block of glutamatergic (20μM NBQX, 50μM D-AP5) as well as GABAergic (1μM Gabazine, 1μM 
CGP) transmission does not abolish the AP-induced hyperpolarization. (A) Example wc recording 
of a reactive CA3 PC in response to the AP train (rectangle). (B) The ΔVm of each recorded cell 
(circles) and the median, 25th and 75th percentile of the average ΔVm of all reactive cells is shown 
for n(N)=8(2) experiments (-4.8, -8.3 and -3.8mV; left). The % of reactive cells is 62.5% (right). 
(C) Dual pp recording of 2 CA3 PCs. AP firing in a control cell (lower trace) elicits a 
hyperpolarization in this, but not in the other cell (upper trace). The AHPs of the control cell are 
clipped for display purposes. (D) In 5/5 recordings (N=5), the control cell hyperpolarized in 
response to the AP trains (filled grey circles, ΔVm: -6.0±1.5mV), whereas the unstimulated cell 
did not (open black circles, ΔVm: 0.02±0.6mV). (E-F) CB2R agonists cannot mimic CB1R-
mediated depression of synaptic transmission. (E) HU has no effect on DSI-positive eIPSCs. Left: 
example of a CA3 PC recorded in wc configuration. Depolarization of the neuron results in a 
transient reduction of eIPSC amplitude, whereas bath application of HU does not. Right: mean 
normalized eIPSC amplitudes of n(N)=5(4) experiments for DSI (0.7±0.03) and HU application 
(1±0.05) in comparison to baseline (paired t-test: P=0.0016 and P=0.67). (F) WIN, but not HU, 
suppresses evoked field responses in CA3. Left: exemplary fEPSP recording with HU and WIN 
bath application. Right: mean normalized fEPSP slopes for HU (1±0.03) and WIN (0.7±0.05) in 
comparison to baseline (paired t-test: P=0.33 and p<0.001). 
Figure 8. Functional relevance of CB2R activation probed in vitro and in vivo.  
(A-C) Physiological spike trains trigger long-lasting hyperpolarization. (A) Schematic of the 
presented PST (upper panel) as well as a segment of an exemplary Vm trace of a rat CA3 PC that 
fires in response to the respective stimulus (lower panel). (B) Vm time plot of the same CA3 PC 
responding to the PST (rectangle) with a long-lasting hyperpolarization. (C) Left: the ΔVm of each 
recorded cell (circles) and the median, 25th and 75th percentile of the average ΔVm of reactive rat 
CA3 PCs (wc, n(N)=16(6): -4.5, -6.7 and -2.7mV). Right: % of reactive cells (50%).  
(D-F) CB2R activation reduces the spike probability of CA3 PCs. (D) The spike probability of a 
CA3 PC in response to the application of the CB2R agonist HU. Example traces show spikes 
elicited by synaptic stimulation during control conditions (black) and 5min after HU application 
(red). The baseline and hyperpolarized Vm values are indicated below the traces. (E) Time plot of 
the Vm (circles) of the same cell and its AP firing (vertical lines) for each given Vm. (F) Summary 
graph of the spike probability for n(N)=5(3) reactive cells under baseline and agonist conditions 
(0.8±0.02 and 0.14±0.04 respectively). The change in spike probability was accompanied by an 
average Vm hyperpolarization of -6.3±0.3mV.  
(G-H) CB2Rs regulate hippocampal gamma oscillations in vivo: altered coupling of gamma and 
theta oscillations after HU application. (G) LFP signal traces (1-150Hz band-pass filtered) 
recorded in the CA3 area during exploratory behavior before (upper panel) and 30min after (lower 
panel) the i.p. administration of HU (10mg/kg). Note that the typical association of high amplitude 
26 
gamma oscillations with theta oscillation peaks (shades) and low amplitude gamma oscillations 
with theta oscillation troughs is altered after the CB2R agonist administration. (H) The theta 
modulation of slow (30-85Hz) but not intermediate (65-120Hz) gamma oscillations was reduced 
by the agonist administration (vehicle: n(N)=15(10), agonist: n(N)=13(10), F1,13=9.1, P=0.010, 
slow, F1,13=0.0, P=0.86, ANOVA).   
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Supplemental Materials 
Supplemental Figures 
 
 
 
Figure S1. Related to Figure 1. Whole-cell recordings interfere with the Vm hyperpolarisation. (A) Whole-cell 
current-clamp recording of a reactive (left) and an unreactive CA3 PC (right) in response to the AP train stimulus 
(rectangle). (B) Left: the ΔVm of each recorded cell (open circles) and the median, 25th and 75th percentile of the 
average ΔVm recorded in the different recording conditions are shown for pp (data as in Fig. 1) and for n(N)=39(16) 
wc recordings (wc, with n=20 reactive cells: -3.5, -4.9 and -2.5mV). The dashed red line indicates the cut-off of -
2.1mV by which cells were classified as reactive (black circles) or unreactive (grey circles). Right: % of reactive 
cells is shown for pp (100%) and wc (51.2%) recordings. (C-F) Correlation analysis of the ΔVm and recording 
variables: The ΔVm was significantly correlated to the Ra (C) but not the Rin (D), Vm (E) and the constant current 
injection needed to keep the cell at a holding potential of -60mV (F). Both the correlation coefficient (r or rs) and the 
correlation’s significance (p) are given for each correlation. 
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Figure S2. Related to Figure 1. Further analysis of cell-type specificity.  (A-C) A theta-frequency burst protocol 
was used to elicit a total of 3000 action potentials in CA1 PCs recorded in wc configuration. (A) The first ten bursts 
in a recorded CA1 PCs are shown that were repeated 60x over 5 min. (B) The complete induction protocol 
(rectangle) did not induce a long-lasting hyperpolarisation in the same CA1 PC as can be seen in the time plot of its 
Vm. The Vm during the induction protocol is not included for display purposes. (C) Summary plot of n(N)=11(2) 
CA1 PCs with a ΔVm (median, 25th and 75th percentile) of 1.12, 0.22 and 1.63mV (Wilcoxon test: P=0.64 compared 
to baseline). (D-F) CA2 PCs display a hyperpolarisation that is similar to CA3 PCs. (D) Anatomical reconstruction 
of a CA2 PC filled with 30µM Alexa. Note the characteristic bifurcation of the proximal dendritic tree (indicated by 
black arrow). The pyramidal cell layer is indicated by the dashed lines and the axonal projections from DG GCs, the 
mossy fibres (MF) that end at the border of CA3 to CA2, are shown in grey. (E) Time plot of the Vm of the same 
CA2 PC as in (D) in response to the action potential protocol (rectangle) recorded in wc configuration. The dashed 
line indicates the average baseline Vm. (F) The ΔVm of each recorded cell (circles) and the median, 25th and 75th 
percentile of the average ΔVm of all reactive cells are shown for (n(N)=8(5)) CA2 PCs: -5.8, -8.9 and -2.5mV (left). 
The percentage of reactive CA2 PCs was 50% (right). 
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Figure S3. Related to Figure 3. Cannabinoid receptor antagonists abolish the hyperpolarisation. (A) Whole-
cell current-clamp recordings from both CB1R and CB2R KO animal lines confirm the results obtained in pp 
configuration as shown by the exemplary Vm traces of a CB1R-/- (left) and CB2R-/- CA3 PCs (right) recorded in wc 
configuration. (B) Left: summary box plot of the median ΔVm (with 25th and 75th percentile) for reactive CB1R-/- 
CA3 PCs (n(N)=20(5): -5.6, -8.5 and -3.7mV) and all CB2R-/- CA3 PCs (n(N)=15(3): 0.21, -0.31 and 2mV). The Vm 
of CB2R-/- CA3 PCs after the induction protocol did not differ significantly from baseline, whereas it did differ 
significantly for CB1R-/- (paired t-test: P=0.45 and P=0.007 respectively). Right: the percentage of reactive cells for 
all recorded CB1R-/- and CB2R-/- CA3 PCs (50% vs. 13.3%). (C) Summary time course of the average ΔVm in 
response to the action potential stimulus of whole-cell CA3 PCs recordings in slices of WT (n(N)=14(3)) and CB1R 
KO mice (n(N)=15(3)) preincubated in the CBR antagonist 2-5µM AM-251 (left) and slices of CB1R KO mice 
preincubated in the CB2R-specific antagonist 1µM SR (right, n(N)=24(3)). (D) Left: the ΔVm of each recorded cell 
(circles) and the median, 25thand 75th percentile of the average ΔVm are shown for WT in AM-251 (0.72, 0.27 and 
1.5mV), CB1R KO in AM-251 (0.45, -0.56 and 1mV) and CB1R KO in SR (0.88, -0.58 and 2.05mV). Right: the 
percentage of reactive CA3 PCs is shown for WT in AM-251 (7.1%), CB1R-/- in AM-251 (0%) and CB1R-/- in SR 
(6.7%). Filled circles indicate reactive cells. (E) Comparison of intrinsic electrophysiological parameters of CA3 
PCs recorded in pp configuration revealed no significant differences between C57BL/6 WT and the different KO 
mouse strains.  
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Figure S4. Related to Figure 3. Conditional Cnr2 targeting strategy. (A) Cnr2 exons 2 and 3 are indicated as 
boxes, with the Cnr2 coding region in dark green. The targeting vector contained a PGK-neo selection cassette, 
flanked by two FRT sites, in the 3’ UTR. LoxP sequences were inserted in the intron between exons 2 and 3, as well 
as downstream of the PGK-neo cassette. (B) Recombinant ES cell clones were identified by Southern blotting with 
flanking 3’ and 5’ probes. (C) Mice carrying the Cnr2 flox/neo locus were first crossed with a Flp-deleter mouse 
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strain, resulting in offspring with a Cnr2 flox locus. (D) These animals are routinely genotyped by a PCR strategy. 
(E-F) Confocal images of the hippocampus of Syn-Cre- (E) and Rosa26-Stop-tdTomato-Syn-Cre+ reporter mice 
(F). Left panels: Overview of the hippocampus (scale bar: 100µm), right panels: higher magnification (scale bar: 25 
µm) of area CA3. The confocal images clearly show the Syn-Cre expression in the hippocampus. 
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Figure S5. Related to Figure 4. CB2R mRNA expression in the DG, CA1 and CA2 regions of the hippocampus 
as detected by RNAscope ISH. (A) Hippocampal image (DAPI staining), illustrating the target regions. (B-D) 
CB2R mRNA (Cnr2, green) staining and co-localisation of CB2R and NeuN (Rbfox3, red) mRNA in the DG (B), 
CA1 (C) and CA2 (D) of the hippocampus in WT (upper panels) and Syn-CB2R-/- (lower panels) mice, illustrating a 
substantial reduction in CB2R mRNA expression in Syn-CB2R KO compared to WT mice. Note that the overall 
density of CB2R mRNA in the DG and area CA1 is much lower than that in area CA2 or CA3 (see Figure 4). 
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Figure S6. Related to Figure 4. CB2R mRNA expression in area CA3 of mouse hippocampus by classical ISH 
assay. (A) The CB2R mRNA structure in const. CB2R-/- mice and the target region of a CB2R probe used to detect 
CB2R mRNA in the hippocampus of WT, CB1R-/- and CB2R-/- mice. This CB2R-riboprobe targets the deleted region 
of the Cnr2 gene in CB2R-/- mice. (B) The CB2R-riboprobe detected CB2R mRNA in the CA3 region of 
hippocampus in WT and CB1R-/-, but not in CB2R-/- mice. (C-D) Double-label fluorescent images, illustrating CB2R 
mRNA (by ISH, red) is co-localised with  NeuN (immunostaining, green) in hippocampal neurons (C) and also with 
vGluT2 (immunostaining, green) in hippocampal glutamatergic neurons (D) in WT mice. 
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Figure S7. Related to Figure 5. Control of conductance-based Rin change mediated by adenosine-
dependent activation of GIRK. (A) As a control, the relative change in Rin in response to 1µM 
Adenosine (n(N)=5(2): 0.67±0.08) is shown that was reversed by the application of the GIRK blocker 
10µM SCH-23390 (1.01±0.02). (B) Acute application of SCH-23390 does not reverse the agonist- or AP-
induced hyperpolarisation and thus excludes the involvement of GIRK channels. Left: single experiments 
(grey circles) and mean±SEM of n(N)=3(2) wc recordings showing the ΔVm in HU and after SCH-23390 
application (-9.3±1.8 and -8.9±1.8mV, paired t-test: P=0.82). Right: single experiments (grey circles) and 
mean±SEM of n(N)=3(2) pp recordings showing the ΔVm after AP induction and with subsequent SCH-
23390 application (-4±0.4 and -4.2±0.5mV, paired t-test: P=0.83). 
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Figure S8. Related to Figure 6. Washin of the CB2R inverse agonist SR acutely reverses the AP-induced 
hyperpolarisation. PP recordings of CA3 PCs in CB1R KO and WT mice show that the Vm hyperpolarisation can 
be reversed by washin of 1µM SR. (A) Exemplary time plot of the Vm of a WT CA3 PC that was recorded for 
>15min post induction (AP train: rectangle). (B) Summary time plot of the average ΔVm from n(N)=5(5) control 
WT CA3 PCs. At min15-20 the ΔVm is still significantly different from baseline (-3.07±0.29mV; paired t-test: 
p<0.05). Note that this data is also included in Fig. 1. (C) Exemplary recordings of CB1R-lacking CA3 PCs in which 
SR (grey) was washed in at different time points after the induction. (D) Summary time plot of n(N)=7(6) 
experiments in CB1R KOs. (E) Before-after plot of each experiment showing the maximal ΔVm after the AP train 
and the average ΔVm of 10-15min after wash-in of SR. The mean average ΔVm after the AP train (-3.6±0.63mV) 
after the AP train is significantly different from the mean ΔVm after SR application (0.48±0.62mV; Wilcoxon 
matched pairs test: P=0.016). Furthermore, the Vm in SR does not differ from baseline values (Wilcoxon test: 
P=0.47). 
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Figure S9. Related to Figure 8. Reduced power of gamma oscillations in area CA3 in Syn-CB2R-/- mice. 
Average LFP power spectra (A) and cumulative power (B) in the 30-85Hz frequency band (grey rectangle in (A)) of 
control Syn-CB2R+/+ (n(N)=13(4)) and Syn-CB2R-/- mice (n(N)=16(5), F1,20=6.8, P=0.02). Data are presented as 
mean± SEM.  
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Supplemental Methods 
Ethics statement and animal handling. 
Animal husbandry and experimental procedures were performed in accordance with the guidelines of local 
authorities (Berlin, Germany), the German Animal Welfare Act and the European Council Directive 86/609/EEC. 
Animals were housed on a 12:12h day-night cycle with food and water available ad libitum. Constitutive CB1R-, 
CB2R-, and DAGLα KO mice (Buckley et al., 2000; Jenniches et al., 2015; Zimmer et al., 1999) were bred using a 
homozygous breeding protocol. Additionally, a subset of constitutive CB2R KO mice was bred from heterozygous 
parents and their WT littermates were used as controls. Neuron-specific, conditional KO mice for CB2R were 
generated using the Cre/loxP technology. To this purpose, transgenic mice expressing Cre recombinase under the 
Synapsin I promoter were bred with floxed CB2R animals (see below). In this case, Cre-negative offspring was used 
as a control. DNA isolation and genotyping were performed according to standard protocols. All KO mice were 
maintained on a C57BL/6J genetic background. 
 
Generation of conditional CNR2 knockout mice. 
Two loxP sites were inserted into the Cnr2 gene flanking the coding exon 2 by homologous recombination into 
embryonic stem cells. An FRT-flanked neo selection cassette was also inserted upstream of the loxP site in the 3’ 
untranslated region. Recombinant ES cell clones were identified by Southern blotting with flanking 5’ and 3’ 
probes. One clone was used for the generation of chimeric animals. Mice with the recombinant Cnr2-flox/neo locus 
derived from these chimeras were mated with a Flp-deleter strain in order to remove the PGK-neo selection cassette, 
resulting in a floxed Cnr2 locus (see Figure S3). To control for the specific expression of Cre under the Synapsin 
promoter, Syn-Cre mice were bred with the Rosa-26-Stop-tdTomato reporter line. Rosa-CAG-LSL-tdTomato-
WPRE:deltaNeo has a loxP-flanked STOP cassette preventing transcription of the downstream red fluorescent 
protein variant (tdTomato). When bred to mice that express Cre recombinase, the resulting offspring will have the 
STOP cassette deleted in the cre-expressing tissue(s) resulting in expression of tdTomato (Madisen et al., 2010). The 
brains of the offspring were removed, snap-frozen in isopentane on dry ice and stored at -80°C until use. Brains 
were then embedded in Tissue-Tek® and consecutively sectioned at 16µm using a Leica cryostat and stored at -
20°C until use. The sections were covered with Fluromont and images were acquired on a Zeiss Axioplan confocal 
microscope. 
 
In vitro electrophysiology.  
Slice preparation. Hippocampal slices were prepared from P21-P35 C57BL/6 and KO mice, and Wistar rats (where 
indicated). Animals were anesthetised with isoflurane and decapitated. Their brains were quickly removed and 
transferred to sucrose-based ice-cold artificial cerebrospinal fluid (aCSF) containing (in mM): 87 NaCl, 26 
NaHCO3, 50 Sucrose, 10 Glucose, 2.5 KCl, 1.25 NaH2PO4, 3 MgCl2, 0.5 CaCl2 for mice and 87 NaCl, 26 NaHCO3, 
75 Sucrose, 25 Glucose, 2.5 KCl, 1.25 NaH2PO4, 3 MgCl2, 0.5 CaCl2 for rats, respectively. Tissue blocks containing 
the hippocampus were mounted on a VT1200SVibratome (Leica, Germany) and horizontal slices of 300µm 
thickness were cut. Slices were subsequently stored for 1-5h in an interface chamber (Haas et al., 1979) at near-
physiological temperature (~35°C) and superfused with aCSF containing (in mM): 119 NaCl, 26 NaHCO3, 10 
Glucose, 2.5 KCl, 1 NaH2PO4, 1.3 MgCl2, 2.5 CaCl2 (pH 7.4; 285-300mOsm; ~1ml/ min). All aCSF was 
equilibrated with 95% O2 and 5% CO2.  
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General setup. Individual hippocampal slices were transferred to a submerged chamber (Luigs and Neumann, 
Germany), perfused with aCSF (~5ml/ min, heated to 33-34°C) and visualised with infrared differential interference 
contrast optics on an Olympus BX-51 WI microscope. Extracellular field and patch-clamp recordings were 
performed with a MultiClamp 700A amplifier (Axon Instruments, USA) and monitored using an HM1507-3 
oscilloscope (Hameg, Germany). Signals were filtered at 2-4 kHz, digitised at 5-10 kHz with 16-bit resolution using 
a BNC-2090 interface board (PCI 6035E A/D Board, National Instruments, USA) and recorded in IGOR Pro 5.0 
(WaveMetrics Inc., USA) with custom-made plug-ins. Putative hippocampal principal cells were identified based on 
their location, morphology and electrophysiological properties. CA2 PCs were additionally filled with 30µM Alexa 
and post-hoc identified under a fluorescence microscope (Leica DMI4000 B, Germany) according to their dendritic 
arborisation. They can be distinguished from neighbouring CA3a PCs by their characteristic dendritic bifurcation 
close to the soma (Wittner and Miles, 2007).  
Pharmacological agents. All drugs were purchased from Tocris (Germany) or Cayman Chemical (via Biomol, 
Germany). If not stated otherwise, experiments were performed in the continuous presence of GABAA- and 
GABABR blockers (1µM gabazine and CGP55845 respectively) to isolate excitatory transmission, and 100nM 
NBQX to prevent epileptiform activity. For recording GABAAR-mediated eIPSCs, the aCSF was supplemented with 
25µM D-AP5, 10µM NBQX and 1µM CGP55845 to block AMPAR-, NMDAR- and GABABR-mediated 
transmission respectively. Field recordings were performed in aCSF only. Additional drugs were bath applied to the 
whole slice. CBR (inverse) agonists used were the following: AM-251 (2-5µM), SR (1µM), 2-AG (10µM), WIN 
55,212-2 (1µM) and HU-308 (1µM). 
Whole-cell and perforated patch recordings. Patch pipettes were pulled from borosilicate filamented glass 
capillaries (Harvard Apparatus, UK; 1.5 mm OD) with a DMZ Universal Puller (Zeiss, Germany) and fire-polished 
to a final resistance of 2-3 MΩ for wc recordings. Pipettes were backfilled with filtered internal solution containing 
(in mM): 130 KMeSO3 (or, in some experiments, 140 KMeSO4), 10 KCl, 10 HEPES, 4 NaCl, 4 Mg-ATP, 0.5 Na-
GTP, 5 phosphocreatine, 285–290 mOsm, pH was adjusted to 7.3 with KOH. For pp recordings, pipettes with a final 
resistance of 3-4 MΩ were tip-filled with the same internal solution. They were then backfilled with internal 
solution additionally supplemented with gramicidin (80µg/ml) which was prepared as a stock solution (20mg/ ml, 
diluted in DMSO) on the day of use. For experiments with intracellular application of the non-hydrolysable GDP 
analogue GDP-β-S, Na-GTP in the internal solution was replaced with GDP-β-S, which was added freshly on the 
day of use. 
All recordings, unless indicated differently, were performed in current-clamp mode. The resting Vm and input 
resistance (Rin) were determined directly after establishing the wc configuration or, for pp recordings, when the 
access resistance (Ra) had stabilised. Experiments were only continued if cells had a resting Vm more hyperpolarised 
than -55mV (not corrected for liquid junction potential, LJP). The cells were further characterised by recording their 
membrane response / firing pattern to current injections of increasing strengths (-20 to +800pA, increment: 20-
50pA, 1s). Afterwards, the Vm was adjusted to -60mV with continuous current injection if not stated otherwise. Rin, 
Ra and pipette capacitance were monitored continuously throughout the experiment and the latter two were 
compensated for using bridge balance and capacitance neutralisation. For pp recordings, only cells with a stable Ra 
below 60MΩ were used, with the exception of the dual pp experiments, where the control cell was used if a Ra 
below 100MΩ was achieved. Experiments were stopped if cells depolarised by more than 5mV or the Ra changed > 
10% over the course of the recording.  
Action potential protocols. The standard AP protocol used consisted of 15 trains with 50 APs each (750 APs, inter-
stimulus interval: 10ms, inter-train interval: 20s). Individual APs were elicited by 2ms long, somatic current 
injections (1-2nA). The theta-burst protocol used to test the induction threshold of CA1 PCs consisted of 10 bursts 
of five stimuli (applied at 100Hz) with a 200ms inter-burst interval, repeated every 5s 60x (3000 APs). For the 
construction of the physiological spike train (PST), the unit activity of a putative CA3 place cell recorded in a rat 
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traversing a linear track rat was used (Diba and Buzsáki, 2008; Schmidt et al., 2009). More specifically, an AP 
protocol was implemented using a 5min stretch of inter-spike intervals of this cell’s place field firing pattern. 
Because the PST stemmed from rat data, this dataset was acquired in rat accordingly.  
Recordings of IPSCs. Pharmacologically isolated (25µM AP5 and 10µM NBQX), evoked IPSCs (denoted as eIPSCs 
in figures) were recorded in voltage-clamp configuration at a holding potential of -50 or -70mV (resulting in either 
out- or inward currents). The stimulation electrode (borosilicate glass, as above) was positioned in stratum radiatum 
of CA3 ~150µm away from the recorded cell (towards the hilar region of the dentate gyrus) and the experiment were 
only started when the evoked IPSCs displayed monosynaptic rise and decay kinetics. DSI was elicited by 
depolarising the cell to 0mV (3x 1s, 5s interval or 1x 5s). Cells that showed a >15% reduction in the amplitude of 
the evoked IPSCs after the depolarising step were considered DSI-positive. Pharmacologically isolated (25µM AP5 
and 10µM NBQX), spontaneous IPSCs for the analysis of DSI were recorded with an internal solution containing 
140mM KCl to reverse and increase the driving force for chloride and in the presence of 20µM carbachol to boost 
their frequency.  
Recordings of synaptically evoked EPSPs and action potentials. To test for the change in spike probability of CA3 
PCs before and after pharmacological CB2R activation, a stimulation electrode was placed in stratum radiatum of 
CA3 and synaptic, glutamatergic responses (EPSPs) were evoked and recorded in current clamp in the continuous 
block of GABAergic transmission. The stimulation strength was adjusted to an initial spike probability of ~80%.  
Extracellular field recordings. For field recordings, both the stimulation and recording pipette (borosilicate glass, as 
above; tip diameter: ~20µm) were filled with aCSF and placed in stratum radiatum of area CA3. Field EPSPs were 
evoked by stimulating presumptive associational/commissural fibres (duration: 100µs, frequency: 0.05Hz) using a 
stimulus isolator (Isoflex, A.M.P.I) and adjusted to 60% of the maximal amplitude. The fEPSP slopes were 
determined as dV/dt (in mV/ms) of 10 to 90% of the amplitude in each individual trace.  
Data analysis. Data analysis was performed in IGOR Pro 6.12 using the IGOR analysis software package 
Neuromatic (www.neuromatic.thinkrandom.com). Statistical comparisons between groups were performed in 
GraphPad Prism (GraphPad Software, USA). Sample sizes are given as the number of experiments (n) and the 
number of animals (N). Individual membrane potential values (denoted as Vm in figures) were determined from a 
10ms average around the detected minimum within a 100ms time window every 20s. The minimum average was 
taken to circumvent distortions due to the high spontaneous activity in CA3 PCs. Vm values are not corrected for 
LJP, which was calculated to be 10mV (JPCalcW, Molecular Devices; USA) (Barry, 1994) for the KMeSO3-based 
internal solution. The Rin was calculated from a 50ms average of the steady-state Vm response to a hyperpolarising 
test pulse (400ms, -20 to -80pA). Given Vm values were normalised to a 1min baseline (3 values) before the AP 
induction protocol or, for drug application, to a 2min baseline. For summary time plots of the global Vm average, the 
individual values of all experiments were averaged per point in time; alternatively, the median (including 25th and 
75th percentile) at a certain time point is calculated as the average of 1min (3 values/ experiment). For the analysis of 
spontaneous IPSCs (denoted as sIPSCs in figures), individual events were detected with a threshold-based algorithm 
in Neuromatic and a total of 5-10s were analysed for each time point. The amplitude of each event was defined as 
the 10ms average maximum within a 100ms time window after the stimulation. Examples show individual traces.  
The distribution of data was assessed with the D’Agostino and Pearson omnibus normality test. Normally distributed 
data sets were compared with a two-tailed Student‘s t-test and values are expressed as mean±SEM. Nonparametric 
tests were used as indicated and data presented as median (including the 25th and 75th percentile). The averages of 
the change in membrane potential (ΔVm) across cells were assessed with the appropriate paired tests (Student’s t-test 
or, if indicated, Wilcoxon signed-rank test). Correlation analyses were carried out using either the Pearson (for data 
sampled from Gaussian distribution, indicated by r) or Spearman (nonparametric, indicated by rs) correlation 
coefficient. Results were considered significant at p<0.05. The percentage of reactive cells in each experiment was 
calculated from a -2.1mV cut-off to facilitate the comparison between different (recording-) 
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conditions/manipulations. This cut-off was based on the mean of the wc hyperpolarisation (-1.8mV) plus its standard 
error (-0.3mV). To give a ‘biologically relevant’ estimate of the average ΔVm, only the values of reactive cells are 
averaged for data sets in which washout in the wc configuration led to a skewed data distribution.  
The electrophysiological analysis of the const. (1) and cre-dependent (2) CB2R KO animals, were partially (1) and 
fully (2) performed in a blind and interleaved manner. In case of the const. CB2R KOs, the results of cells from 
heterozygously bred WT and KO littermates, that were recorded and analysed blind, were not different from 
homozygously bred KO and C57BL/6 WT mice (Mann-Whitney test: P=0.8) and the data was thus pooled.  
 
In vivo electrophysiology.  
Wire array recordings. After one week of handling and habituation to the recording room, mice were implanted 
under isoflurane anesthesia with arrays of single tungsten wires (40µm, California Fine Wire Company) in the CA3 
area (coordinates relative to bregma, anteroposterior: -1.94mm, lateral: 2.3mm, ventral: 2.15mm). Reference and 
ground electrodes were miniature stainless-steel screws in the skull above the cerebellum. Implanted electrodes were 
secured on the skull with dental acrylic. After one week of recovery, animals were placed in a 1x1m open arena and 
were allowed to explore freely during recordings. Electrodes were connected to operational amplifiers (Neuralynx, 
USA) to eliminate cable movement artefacts. Electrophysiological signals were differentially amplified, bandpass 
filtered (1-9000Hz) and acquired continuously at 30303Hz. After 1h of baseline recordings animals were injected 
with either vehicle (10mg/kg DMSO) or with HU-308 (10mg/kg, dissolved in DMSO) and were recorded in the 
arena for one more hour. After completion of the experiments, mice were deeply anesthetised and electrolytic 
lesions at selected recording sites were performed. Subsequently the animals were perfused intracardially with 4% 
PFA solution and decapitated. Brains were fixed, cut into 50µm slices and stained with cresyl violet for confirmation 
of recording sites. 
Data analysis. Signal processing was carried out off-line by custom-written MATLAB algorithms. The LFP was 
processed by low-pass filtering and down-sampling of the wideband signal to 1250Hz. Phase-amplitude coupling of 
theta and gamma oscillations was assessed for epochs of theta oscillations with a theta/delta power ratio of at least 
five. The theta phase was obtained by Hilbert transformation of the 5-10Hz filtered signal. Gamma oscillation peaks 
were detected in the 30-85Hz and 65-120Hz band-pass filtered signal, and their amplitudes and theta phases were 
subsequently calculated. The gamma amplitude – theta phase modulation coefficient was computed as a correlation 
coefficient (Fisher z-transformed, Pearson’s or Spearman’s, depending on the distribution normality) between the 
gamma modulation depth (Wulff et al., 2009) and the theta/delta ratio-standardised amplitude of the concurrent theta 
oscillation. Power spectral density was computed using the multitaper method (NW 3, window size 1024) and 
standardised to the power in the 30-45Hz band during baseline recordings. The statistical significance of 
comparisons was determined by a two-way ANOVA (subject x treatment and subject x genotype).  
 
In situ hybridisation and immunohistochemistry 
Classical In situ hybridisation. Animals (WT, CB1R−/−, and CB2R−/−; 2 mice each strain) used in this experiment 
were matched for age (6-8weeks) and weight (20–30g). The const. CB2R−/− mice are C terminal-deleted, in which 
the last 341bp on exon 3 are deleted that encode parts of the intracellular and extracellular third loops, 
transmembrane regions 6 and 7, and the intracellular C terminus (Buckley et al., 2000; Zhang et al., 2014). These 
animals were deeply anesthetised and transcardially perfused with saline, followed by 4% Paraformaldehyde (PFA). 
CB2R-mRNA riboprobe was synthesised as described in our previous report (Zhang et al., 2014). The ISH 
procedures for hippocampal CB2R mRNA expression were the same as reported previously (Lanciego et al., 2011; 
Zhang et al., 2014).  To determine the phenotype of mCB2R mRNA-expressing neurons in hippocampus, we used 
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fluorescent IHC to label all neurons with a NeuN antibody or glutamatergic neurons with a vGlut2 antibody, 
respectively. After the mCB2R mRNA staining in freely floating coronal slices by classical ISH, the sections were 
incubated with a mouse anti-NeuN antibody (1:1,000; Millipore) or a mouse anti-vGlut2 antibody (1:500; Millipore) 
at 4°C overnight, followed by Alexa Fluor 488 goat anti-mouse IgG (1:500; Molecular Probes) at RT for 2h. The 
sections were mounted on glass slides, air-dried at RT, and coverslipped with Fluorogel and Tris buffer (Electron 
Microscopy Sciences). 
RNAscope In situ hybridisation. Animals (WT, Syn- CB2R-/-, and CB2R-/- mice; 2-3 mice each strain, age 4-8 weeks) 
were perfused with saline to wash out blood cells in the brains, and then quickly decapitated. The whole brains were 
taken out, quickly frozen on dry ice, and then stored at -80°C for CB2R RNAscope ISH assays. The brains were 
sectioned coronally (14µm thick, -2.8mm posterior to bregma) to sample the hippocampus (Paxinos and Watson, 
2005). The freshly frozen sections were then mounted on positively charged microscopic glass slides (Fisher 
Scientific). A CB2R-specific probe (Mm-Cnr2-O2) that targets the Cnr2 gene-deleted region on exon 3 (506-934bp 
of NM_009924.4) and a NeuN probe (Mm-Rbfox3-C2) that targets 1827-3068bp of NM_001039167.1 were 
designed and provided by Advanced Cell Diagnostics Inc. The CB2R/NeuN mRNA staining was performed 
following the User Manual for Freshly Frozen Tissue using the RNAscope Multiplex Fluorescent Reagent Kit 
(Advanced Cell Diagnostics). Stained slides were coverslipped with fluorescent mounting medium (ProLong Gold 
Antifade Reagent P36930, Life Technologies) and scanned into digital images with an Olympus FluoView FV1000 
confocal microscope at 60× magnification using manufacturer-provided software. 
Fluorescence-activated cell sorting (FACS). The frozen, -80°C cold whole brains were then put into a -20°C 
cryostat to equilibrate for at least 30min before dissection. The dissection procedure was the same as reported 
previously (Li et al., 2015; Liu et al., 2014; Rubio et al., 2015) with very minor modifications.  Briefly, 1.5mm thick 
coronal hippocampal sections were cut at the levels of bregma - 2.27 and - 3.77mm, and then hippocampal tissues 
were punched with a 24gauge neuron punch needle (Fine Science Tools). After finely mincing the hippocampal 
tissue with razor blades on ice, it was transferred into 1ml of ice-cold Hibernate A (HA-if, Brain Bits). After 
centrifuging at 3,000rpm (4°C) for about 2min, the supernatant was discarded and the pellets were re-suspended in 
0.6ml of ice-cold Hibernate A. Each sample was first triturated 10x in series using fire-polished glass pipettes (with 
successively smaller diameters of 1.0mm and 0.4mm), and then the samples were triturated for additional two times 
with 0.4mm-diameter glass pipettes. Each trituration step consisted of triturating up and down at least 1x. After 
centrifuging for 5min at 3,500rpm (4°C), the collected cells were re-suspended with 0.5ml of ice-cold Hibernate A. 
The cell pellets were then fixed and permeabilised by adding the same volume of 100% of cold ethanol (-20°C) for 
15min on ice. After centrifuging for 4min at 4,000rpm (4°C), the cell pellets were re-suspended with 0.5ml PBS and 
incubated with a PE-labeled (fluorescent) anti-NeuN antibody (1:500; FCMAB317PE, Millipore) at 4°C for 30min. 
Then the cells were washed 3x with 0.5-1.0ml cold PBS. After the cells were filtered with 40µm cell strainers 
(Falcon brand; BD Biosciences), NeuN-positive and NeuN-negative cells were sorted by a FACSAria I cell sorting 
system (BD Biosciences). The sorted neurons or cells can be identified by the distinct forward (FSC) and side (SSC) 
scatter properties. DAPI (1 µg/ml, staining DNA) staining indicated that 98% of the events in the neuronal gate are 
DAPI-positive events (nucleated cells). After defining the cell population, we gated single cells by FCS width and 
height, in which ~98% of single cells were DAPI positive. This single-cell population was sorted again to separate 
NeuN-positive hippocampal neurons (with PE fluorescent signal) and NeuN-negative non-neuronal cells (not PE 
fluorescent) (approximately 5000 cells for each group) for the following CB2R mRNA qPCR assays. The sorted 
cells were collected into 1.5ml Eppendorf tube containing 50µl extraction buffers (PicoPure RNA isolation kit, 
Arcturus Bioscience) and then suspended by pipetting up and down 10x, followed by incubation at 42°C for 30min. 
After centrifuging the suspension at 3,500 at 4°C for 2min, the supernatant were collected for the RNA extraction 
according to the manufacturer’s protocol for using PicoPure RNA isolation kit (Arcturus Bioscience) to extract 
RNA. After the RNA extraction, the cDNA was synthesised by use of Superscript III first strand cDNA synthesis kit 
(Invitrogen). We used gene-targeted preamplification of cDNA as described previously (Li et al., 2015; Liu et al., 
2014; Rubio et al., 2015). First, we pooled TaqMan ABI primer/probes (20×TaqMan gene expression assay as a 
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stock solution) for all the target genes listed in Table 1. Each cDNA sample (10µl) was mixed with the pooled 
primer solution (10µl) and 20µl of 2×TaqMan PreAmp Master Mix (Applied Biosystems). The cDNA 
preamplification was performed in a Veriti 96-well Thermal Cycler (Applied Biosystem) using the following 
program: 95°C hold for 10min, denaturation at 95°C for 15s, and annealing and extension at 60°C for 4min (14 
cycles). The preamplified cDNA product was diluted 10x before proceeding for qPCR assays. The qPCR was 
performed in duplicates with a FAM-labeled probe for each target gene and a VIC-labeled probe for an endogenous 
control gene (Gapdh). We used TaqMan Advanced Fast PCR Master Mix (7500 Fast TaqMan instrument, Life 
Technologies) for qPCR, using the following program: 95°C hold for 20s, then 40 cycles with denaturation at 95°C 
for 3s, and annealing and extension at 60°C for 30s. The ΔΔCt method with Gapdh as the housekeeping gene was 
used to analyse the PCR reactions. The uniformity of the preamplification was verified by comparing cDNA 
templates with the unamplified and preamplified samples (data not shown).   
 
Table 1. Related to experimental procedures. Gene expression assays and primer or probe sequences for FACS	  
Gene (Protein) TaqMan probe
a or 
Assay IDb/Cat. noc Forward primer Reverse primer 
Cnr2 (CB2R) ATGCTGGTTCCCTGCACa AGCTCGGATGCGGCTAGAC AGGCTGTGGCCCATGAGA 
Cnr1 (CB1R) Mm01212171_s1b   
Rbfox3 (NeuN) Mm01248771_m1b   
Itgam (CD11b) Mm00434455_m1b   
Cspg4 (NG-2) Mm00507257_m1b   
Aldh1l1 
(ALDH1L1) 
Mm03048957_m1b   
Gapdh (GAPDH) 4352339Ec   
 
Statistics analysis. Data is presented as mean ± S.E.M. One-way ANOVA was used to analyse the difference 
between WT and 2 CB2R-KO mice in terms of different target gene expression in NeuN-positive and NeuN-
negative cells. Individual group comparisons were carried out using the Student–Newman–Keuls method. 
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